It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Different conclusions about memantine.
https://arctichealth.org/en/permalink/ahliterature161328
Source
Can Fam Physician. 2007 Mar;53(3):403-4; author reply 404
Publication Type
Article
Date
Mar-2007
More detail
Author
Joel Lexchin
Source
Can Fam Physician. 2007 Mar;53(3):403-4; author reply 404
Date
Mar-2007
Language
English
Publication Type
Article
Keywords
Aged
Aged, 80 and over
Alzheimer Disease - diagnosis - drug therapy
Canada
Dose-Response Relationship, Drug
Drug Administration Schedule
Excitatory Amino Acid Antagonists - adverse effects - therapeutic use
Female
Humans
Male
Memantine - adverse effects - therapeutic use
Randomized Controlled Trials as Topic
Risk assessment
Sensitivity and specificity
Severity of Illness Index
Treatment Outcome
United States
Notes
Cites: N Engl J Med. 2003 Apr 3;348(14):1333-4112672860
Cites: Int J Geriatr Psychiatry. 1999 Feb;14(2):135-4610885864
Cites: Stroke. 2002 Jul;33(7):1834-912105362
Cites: Int Clin Psychopharmacol. 2002 Nov;17(6):297-30512409683
Cites: Can Fam Physician. 2007 Jan;53(1):50-417872609
Cites: Med Lett Drugs Ther. 2003 Sep 15;45(1165):73-412968123
Cites: Drug Ther Bull. 2003 Oct;41(10):73-614593973
Cites: JAMA. 2004 Jan 21;291(3):317-2414734594
Cites: Prescrire Int. 2003 Dec;12(68):203-514986682
Comment On: Can Fam Physician. 2007 Jan;53(1):50-417872609
PubMed ID
17872671
View in PubMed
Less detail
Permalink